Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2026-01-08 @ 12:34 PM
Study NCT ID:
NCT02760433
Status:
COMPLETED
Last Update Posted:
2023-09-21
First Post:
2016-04-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease
Sponsor:
R-Pharm International, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-25
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-10-01
Completion Date Type:
ACTUAL
First Submit Date:
2016-04-29
First Submit QC Date:
None
Study First Post Date:
2016-05-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-01-26
Results First Submit QC Date:
None
Results First Post Date:
2021-07-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-19
Last Update Post Date:
2023-09-21
Last Update Post Date Type:
ACTUAL